COVID-19 Vaccine

1. BRANDS

1.1. PFIZER

1.2. SINOVAC

1.3. ASTRAZENECA

1.4. MODERNA

1.5. NOVAVAX

1.6. COVAX

2. PRIORITY GROUPS

2.1. A1

2.1.1. FRONTLINE WORKERS IN HEALTH FACILITIES

2.2. A2

2.2.1. SENIOR CITIZENS

2.3. A3

2.3.1. PERSONS WITH COMORBIDITIES

2.4. A4

2.4.1. FRONTLINE PERSONNEL IN ESSENTIAL SECTORS

2.5. A5

2.5.1. INDIGENT POPULATIONS

2.6. B1

2.6.1. TEACHERS, SOCIAL WORKERS

2.7. B2

2.7.1. OTHER GOVERNMENT WORKERS

2.8. B3

2.8.1. SOCIO-DEMOGRAPHIC GROUPS AT SIGNIFICANTLY HIGHER RISK

2.9. C

2.9.1. REST OF THE FILIPINO POPULATION

3. APPROVAL

3.1. WORLD HEALTH ORGANIZATION (WHO)

3.2. FOOD AND DRUG ADMINISTRATION (FDA)

4. TEST TRIALS

4.1. PRECLINICAL STAGE

4.1.1. HOW WILL THE VACCINE WORK?

4.2. PHASES 1/2A AND 2B

4.2.1. IS IT SAFE? WHAT IS THE RIGHT DOSE?

4.3. PHASE 3

4.3.1. HOW EFFECTIVE IS THE VACCINE?

4.4. REGULATORY APPROVAL AND LICENSURE

4.4.1. IS IT READY FOR THE WORLD?

4.5. PHASE 4

4.5.1. WILL IT STAY SAFE DOWN THE ROAD?